0000899243-19-027220.txt : 20191113
0000899243-19-027220.hdr.sgml : 20191113
20191113190227
ACCESSION NUMBER: 0000899243-19-027220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191111
FILED AS OF DATE: 20191113
DATE AS OF CHANGE: 20191113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayden Michael R
CENTRAL INDEX KEY: 0001352908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 191215768
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z 7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 4155004614
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-11
0
0001785173
89bio, Inc.
ETNB
0001352908
Hayden Michael R
C/O 89BIO, INC.
535 MISSION STREET, 14TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2019-11-11
4
P
0
18750
16.00
A
18750
I
See footnote
Common Stock
2019-11-13
4
C
0
58978
A
77728
I
See footnote
Series A Preferred Stock
2019-11-13
4
C
0
366667
0.00
D
Common Stock
58978
0
I
See footnote
On November 11, 2019, Genworks 2 Consulting Inc. purchased 18,750 shares of the Issuer's common stock at a price of $16.00 per share in the Issuer's initial public offering.
The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date.
These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power.
/s/ Ryan A. Murr, Attorney-in-Fact for Michael R. Hayden
2019-11-13